Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer.

Jadvar H, Chen K, Park R, Yap LP, Vorobyova I, Swenson S, Markland FS.

Amino Acids. 2019 Oct 16. doi: 10.1007/s00726-019-02794-3. [Epub ahead of print]

PMID:
31621030
2.

Methods for Evaluation of a Snake Venom-Derived Disintegrin in Animal Models of Human Cancer.

Swenson SD, Silva-Hirschberg C, Markland FS.

Methods Mol Biol. 2020;2068:185-204. doi: 10.1007/978-1-4939-9845-6_10.

PMID:
31576529
3.

Disintegrin-Integrin Binding for Attachment of Polymer Substrate to the Retina.

Gonzalez-Calle A, Brant R, Diniz B, Swenson S, Markland F, Humayun MS, Weiland JD.

J Clin Exp Ophthalmol. 2018;9(5). pii: 752. doi: 10.4172/2155-9570.1000752. Epub 2018 Oct 8.

4.

A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.

Swenson S, Minea RO, Tuan CD, Thein TZ, Chen TC, Markland FS.

Molecules. 2018 Nov 8;23(11). pii: E2918. doi: 10.3390/molecules23112918.

5.

Multimeric disintegrin protein polymer fusions that target tumor vasculature.

Janib SM, Gustafson JA, Minea RO, Swenson SD, Liu S, Pastuszka MK, Lock LL, Cui H, Markland FS, Conti PS, Li Z, MacKay JA.

Biomacromolecules. 2014 Jul 14;15(7):2347-58. doi: 10.1021/bm401622y. Epub 2014 Jun 25.

6.

Hirudin and s18886 maintain luminal patency after thrombolysis with alfimeprase.

Lee JY, Markland FS, Lucchesi BR.

J Cardiovasc Pharmacol. 2013 Feb;61(2):152-9. doi: 10.1097/FJC.0b013e31827aadbc.

PMID:
23188127
7.

Reversal of thienopyridine-induced platelet dysfunction following desmopressin administration.

Levine M, Swenson S, McCormick T, Henderson SO, Thomas SH, Markland FS.

J Med Toxicol. 2013 Jun;9(2):139-43. doi: 10.1007/s13181-012-0275-6. Erratum in: J Med Toxicol. 2014 Sep;10(3):331.

8.

Snake venom metalloproteinases.

Markland FS Jr, Swenson S.

Toxicon. 2013 Feb;62:3-18. doi: 10.1016/j.toxicon.2012.09.004. Epub 2012 Sep 18. Review.

PMID:
23000249
9.

Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion.

Hubbard S, Choudhary S, Maus E, Shukla D, Swenson S, Markland FS Jr, Tiwari V.

Antivir Ther. 2012;17(7):1319-26. doi: 10.3851/IMP2291. Epub 2012 Aug 8.

PMID:
22875654
10.

Chemical surface modification of parylene C for enhanced protein immobilization and cell proliferation.

Zhang C, Thompson ME, Markland FS, Swenson S.

Acta Biomater. 2011 Oct;7(10):3746-56. doi: 10.1016/j.actbio.2011.06.003. Epub 2011 Jun 12.

PMID:
21689793
11.

Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.

Minea R, Helchowski C, Rubino B, Brodmann K, Swenson S, Markland F Jr.

Toxicon. 2012 Mar 15;59(4):472-86. doi: 10.1016/j.toxicon.2011.02.020. Epub 2011 Feb 24.

12.

The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo.

Lin E, Wang Q, Swenson S, Jadvar H, Groshen S, Ye W, Markland FS, Pinski J.

Prostate. 2010 Sep 1;70(12):1359-70. doi: 10.1002/pros.21173.

PMID:
20623636
13.

Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

Minea RO, Helchowski CM, Zidovetzki SJ, Costa FK, Swenson SD, Markland FS Jr.

PLoS One. 2010 Jun 3;5(6):e10929. doi: 10.1371/journal.pone.0010929.

14.

Fibrolase: trials and tribulations.

Markland FS, Swenson S.

Toxins (Basel). 2010 Apr;2(4):793-808. doi: 10.3390/toxins2040793. Epub 2010 Apr 20. Review.

15.

The use of pepsin in receptor internalization assays.

Helchowski CM, Minea RO, Swenson SD, Markland FS Jr.

Biochem Biophys Res Commun. 2009 Oct 16;388(2):240-6. doi: 10.1016/j.bbrc.2009.07.168. Epub 2009 Aug 8.

PMID:
19665997
16.

Integrin agonists as adjuvants in chemotherapy for melanoma.

Schwartz MA, McRoberts K, Coyner M, Andarawewa KL, Frierson HF Jr, Sanders JM, Swenson S, Markland F, Conaway MR, Theodorescu D.

Clin Cancer Res. 2008 Oct 1;14(19):6193-7. doi: 10.1158/1078-0432.CCR-08-1285.

17.

Self-disgust mediates the relationship between dysfunctional cognitions and depressive symptomatology.

Overton PG, Markland FE, Taggart HS, Bagshaw GL, Simpson J.

Emotion. 2008 Jun;8(3):379-85. doi: 10.1037/1528-3542.8.3.379.

PMID:
18540753
18.

Structure of acostatin, a dimeric disintegrin from Southern copperhead (Agkistrodon contortrix contortrix), at 1.7 A resolution.

Moiseeva N, Bau R, Swenson SD, Markland FS Jr, Choe JY, Liu ZJ, Allaire M.

Acta Crystallogr D Biol Crystallogr. 2008 Apr;64(Pt 4):466-70. doi: 10.1107/S0907444908002370. Epub 2008 Mar 19.

19.

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.

Garcia AA, Hirte H, Fleming G, Yang D, Tsao-Wei DD, Roman L, Groshen S, Swenson S, Markland F, Gandara D, Scudder S, Morgan R, Chen H, Lenz HJ, Oza AM.

J Clin Oncol. 2008 Jan 1;26(1):76-82. doi: 10.1200/JCO.2007.12.1939.

PMID:
18165643
20.

Anti-angiogenesis and RGD-containing snake venom disintegrins.

Swenson S, Ramu S, Markland FS.

Curr Pharm Des. 2007;13(28):2860-71. Review.

PMID:
17979731
21.

Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent.

Minea R, Swenson S, Costa F, Chen TC, Markland FS.

Pathophysiol Haemost Thromb. 2005;34(4-5):177-83.

22.

Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.

Swenson S, Costa F, Ernst W, Fujii G, Markland FS.

Pathophysiol Haemost Thromb. 2005;34(4-5):169-76.

23.

The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model.

Pyrko P, Wang W, Markland FS, Swenson SD, Schmitmeier S, Schönthal AH, Chen TC.

J Neurosurg. 2005 Sep;103(3):526-37.

PMID:
16235686
24.

Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.

Dong D, Ko B, Baumeister P, Swenson S, Costa F, Markland F, Stiles C, Patterson JB, Bates SE, Lee AS.

Cancer Res. 2005 Jul 1;65(13):5785-91.

25.

Potent mimicry of fibronectin-induced intracellular signaling in glioma cells by the homodimeric snake venom disintegrin contortrostatin.

Schmitmeier S, Markland FS, Schönthal AH, Chen TC.

Neurosurgery. 2005 Jul;57(1):141-53; discussion 141-53.

PMID:
15987550
26.

Snake venom fibrin(ogen)olytic enzymes.

Swenson S, Markland FS Jr.

Toxicon. 2005 Jun 15;45(8):1021-39.

PMID:
15882884
27.

Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells.

Golubkov V, Garcia A, Markland FS.

Anticancer Res. 2005 Jan-Feb;25(1A):249-53.

28.

Alpha-fibrinogenases.

Swenson S, Toombs CF, Pena L, Johansson J, Markland FS Jr.

Curr Drug Targets Cardiovasc Haematol Disord. 2004 Dec;4(4):417-35. Review.

PMID:
15578961
29.

Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression.

Swenson S, Costa F, Minea R, Sherwin RP, Ernst W, Fujii G, Yang D, Markland FS Jr.

Mol Cancer Ther. 2004 Apr;3(4):499-511.

30.
31.

Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits angiogenesis.

Zhou Q, Nakada MT, Arnold C, Shieh KY, Markland FS Jr.

Angiogenesis. 1999;3(3):259-69.

PMID:
14517425
32.

Functional effect of contortrostatin, a snake venom disintegrin, on human glioma cell invasion in vitro.

Schmitmeier S, Markland FS, Ritter MR, Sawcer DE, Chen TC.

Cell Commun Adhes. 2003 Jan-Feb;10(1):1-16.

PMID:
12881036
33.

Purification, crystallization and preliminary X-ray analysis of the disintegrin contortrostatin from Agkistrodon contortrix contortrix snake venom.

Moiseeva N, Swenson SD, Markland FS Jr, Bau R.

Acta Crystallogr D Biol Crystallogr. 2002 Dec;58(Pt 12):2122-4. Epub 2002 Nov 23.

PMID:
12454474
34.

A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model.

Markland FS, Shieh K, Zhou Q, Golubkov V, Sherwin RP, Richters V, Sposto R.

Haemostasis. 2001 May-Dec;31(3-6):183-91.

37.

Effect of BJcuL (a lectin from the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and endothelial cells.

de Carvalho DD, Schmitmeier S, Novello JC, Markland FS.

Toxicon. 2001 Oct;39(10):1471-6.

PMID:
11478954
38.
39.

Anti-invasive effect of contortrostatin, a snake venom disintegrin, and TNF-alpha on malignant glioma cells.

Schmitmeier S, Markland FS, Chen TC.

Anticancer Res. 2000 Nov-Dec;20(6B):4227-33.

PMID:
11205252
41.

Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression.

Zhou Q, Sherwin RP, Parrish C, Richters V, Groshen SG, Tsao-Wei D, Markland FS.

Breast Cancer Res Treat. 2000 Jun;61(3):249-60.

PMID:
10966001
42.

Action of metalloproteinases mutalysin I and II on several components of the hemostatic and fibrinolytic systems.

Estêvão-Costa MI, Diniz CR, Magalhães A, Markland FS, Sanchez EF.

Thromb Res. 2000 Aug 15;99(4):363-76.

PMID:
10963787
43.
44.

Contortrostatin activates ERK2 and tyrosine phosphorylation events via distinct pathways.

Ritter MR, Markland FS Jr.

Biochem Biophys Res Commun. 2000 Jul 21;274(1):142-8.

PMID:
10903909
45.

Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom.

Zhou Q, Hu P, Ritter MR, Swenson SD, Argounova S, Epstein AL, Markland FS.

Arch Biochem Biophys. 2000 Mar 15;375(2):278-88.

PMID:
10700384
46.

Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5.

Zhou Q, Nakada MT, Brooks PC, Swenson SD, Ritter MR, Argounova S, Arnold C, Markland FS.

Biochem Biophys Res Commun. 2000 Jan 7;267(1):350-5.

PMID:
10623623
47.

Snake venoms and the hemostatic system.

Markland FS.

Toxicon. 1998 Dec;36(12):1749-800. Review.

PMID:
9839663
49.
50.

Supplemental Content

Loading ...
Support Center